spacer
home > pmps > summer 2018 > the next generation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Next Generation

Efforts to comply with tightening regulatory requirements pertaining to serialisation and track-and-trace capabilities have generated new opportunities to fully digitise the pharmaceutical cold chain, thereby creating the ability to monitor products moving from manufacturers through distribution centres, wholesalers, and logistics partners through last mile distribution, thus improving operational efficiencies and driving more accurate decision-making.

The pharma chain is one of the most complex supply chains globally, given the nature of the industry, the scope and size of the companies that dominate it, and their extended networks of logistics partners. However, it has historically been unwieldy and resistant to transformation.

Over the past two years, the way consumers and regulators have approached the pharma industry has changed significantly, which has pushed pharma enterprises towards an inflection point. Growing consumer expectations, an increase in various multichannel regulatory issues and scrutiny from regulators, and a fluctuation in mergers and acquisition activity have put the supply chain under more pressure than ever before to be redesigned. These pressures grow even more complex and intense across globally distributed organisations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Ada Palmadottir is Business Development Director at Controlant. With more than 20 years in pharmacy, management, and technology, Ada has extensive international experience in sales, operations, and marketing, specifically in the areas of product, vertical alliance sales, and partnerships related to pharmaceutical products. She is a licensed and experienced pharmacist and earned a Master of Pharmacy from the University of Iceland and a Master of Business Administration from the Norwegian School of Management in Oslo. Ada has been working with Controlant’s Cold Chain as a Service solutions for the last six years.
spacer
Ada Palmadottir
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

Philadelphia, USA – September 10, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce the acquisition of San Diego-based Sherpa Clinical Packaging (Sherpa), which expands PCI’s U.S. operations to the West Coast. The acquisition of Sherpa, a provider of clinical trial supply services, further strengthens PCI’s position as a leader in outsourced clinical trial support services. The addition of Sherpa’s capabilities also enables PCI to better support customers from early phases of clinical development through to commercial launch.
More info >>

White Papers

Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?

Clinical Professionals

Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >>

 
Industry Events

BIO-Europe 2018-24th Annual International Partnering Conference

5-7 November 2018, Bella Center Copenhagen, Denmark

The 24th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement